𝔖 Bobbio Scriptorium
✦   LIBER   ✦

P84 High dose epirubicin and cyclophosphamide (EC) vs cyclophosphamide, methotrexate, fluorouracil (CMF) as adjuvant chemotherapy in high risk premenopausal breast cancer patients (PTS). A prospective randomized trial

✍ Scribed by E. Galligioni; G. Cetto; O. Nascimben; A. Buonadonna; D. Crivellari; A. Molino; A. Veronesi; C. Graiff; S. Barni; C. Puccetti; E. Ferrazzi; E. Recaldin; C. Sava; S. Saracchini; C. Sacco


Book ID
117665519
Publisher
Elsevier Science
Year
1998
Tongue
English
Weight
151 KB
Volume
34
Category
Article
ISSN
0959-8049

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Mitoxantrone, 5-fluorouracil, and high d
✍ John D. Hainsworth; Jacques Jolivet; Robert Birch; Lisa G. Hopkins; F. Anthony G πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 106 KB πŸ‘ 2 views

Tenfour patients were treated with NFL: mitoxantrone 12 mg/m 2 IV on Day 1; leuconessee. vorin 300 mg IV over 30-60 minutes on Days 1, 2, and 3, immediately preceding

Adjuvant six cycles of high-dose adriamy
✍ Dr. Takashi Fukutomi; Sadako Akashi; Takeshi Nanasawa; Hiroshi Yamamoto πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 English βš– 398 KB

A prospective randomized study was conducted to compare the adjuvant efficacy of six cycles of high-dose ACMF (Adriamycin, ADM; cyclophosphamide, CPA; methotrexate, MTX; 5-fluorouracil, 5-FU) with that of 12 cycles of low-dose ACMF in premenopausal, node-positive breast cancer patients. The six-cycl